SMTL ID : 5oai.1

Structure of MDM2 with low molecular weight inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x B5K: 3-[(1~{R})-2-(~{tert}-butylamino)-1-[methanoyl-[[3,4,5-tris(fluoranyl)phenyl]methyl]amino]-2-oxidanylidene-ethyl]-6-chloranyl-1~{H}-indole-2-carboxylic acid(Non-covalent)

B5K.1: 14 residues within 4Å: Chain A: L.38, F.39, L.41, G.42, I.45, M.46, Y.51, V.59, F.70, F.75, V.77, H.80, I.83, Y.84 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:L.38, A:L.41, A:I.45, A:Y.51, A:V.59, A:F.75, A:V.77, A:I.83 Hydrogen bonds: A:L.38, A:G.42 Water bridges: A:G.42 pi-Stacking: A:H.80 Halogen bonds: A:H.80

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Skalniak, L. et al., A fluorinated indole-based MDM2 antagonist selectively inhibits the growth of p53wtosteosarcoma cells. Febs J. (2019)

Release Date

2019-02-13

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence